Nuvalent, Inc.

NUVL

Nuvalent, Inc.

NUVL

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-09Shares Purchased (TTM):0Shares Sold (TTM):1,298,440

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:74,319,315Shares Outstanding:78,670,371Institutional Ownership Pct.:94.47%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	160	262	116	127	121	146	369	78	99	335	88	71
Marketable Securities Current	1,128	1,110	827	878	952	973	799	580	593	385	325	360
Prepaid Expense And Other Assets Current	20	20	14	14	13	14	11	8	8	7	7	6
Assets Current	1,308	1,392	957	1,020	1,087	1,132	1,180	666	699	726	420	437
Other Assets Noncurrent	23	20	23	21	19	9	9	9	9	6	5	5
Assets	1,331	1,413	980	1,041	1,106	1,142	1,189	675	708	732	425	442
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	22	30	22	13	26	5	16	7	13	9	10	8
Accrued Liabilities And Other Liabilities	59	61	67	62	49	49	-	-	-	-	-	-
Accrued Liabilities Current	-	-	-	-	-	49	35	31	20	23	19	13
Liabilities Current	81	91	89	75	75	54	51	38	33	32	29	21
Other Liabilities Noncurrent	0	0	0	0	0	0	-	-	-	-	-	-
Liabilities	157	164	135	101	95	72	68	38	33	32	29	21
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	-	-	-	0	0	0
Additional Paid In Capital Common Stock	2,257	2,218	1,697	1,670	1,642	1,617	1,592	1,027	1,007	987	645	637
Accumulated Other Comprehensive Income Loss Net Of…	-1	2	2	1	1	-0	1	-2	-1	0	-1	-2
Retained Earnings Accumulated Deficit	-1,082	-972	-854	-731	-632	-547	-472	-388	-331	-286	-248	-214
Stockholders Equity	1,174	1,248	845	940	1,011	1,070	1,121	637	675	701	396	421
Liabilities And Stockholders Equity	1,331	1,413	980	1,041	1,106	1,142	1,189	675	708	732	425	442
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.80%	20.62%	-	-	-	-	-	-	-	-	-	-
2025	4.20%	11.28%	13.70%	6.13%	12.79%	29.42%	7.85%	5.73%	6.20%	-8.81%	3.54%	-1.57%
2024	-2.81%	12.35%	20.87%	21.20%	41.09%	29.13%	3.65%	-11.22%	-5.69%	4.07%	-4.37%	-2.12%
2023	11.22%	5.19%	20.98%	6.85%	5.73%	17.20%	20.15%	23.02%	30.06%	-12.75%	-29.48%	-20.35%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	16.14	15.27	10.73	13.57	14.48	20.96	23.07	17.44	20.93	22.83	14.42	21.01
Quick Ratio	15.88	15.05	10.58	13.38	14.30	20.70	22.85	17.23	20.70	22.62	14.20	20.74
Working Capital	1.23B	1.30B	867.79M	944.46M	1.01B	1.08B	1.13B	628.07M	666.07M	694.67M	390.67M	416.20M
Leverage & Debt
Debt to Equity	0.13	0.13	0.16	0.11	0.09	0.07	0.06	0.06	0.05	0.05	0.07	0.05
Debt Ratio	0.12	0.12	0.14	0.10	0.09	0.06	0.06	0.06	0.05	0.04	0.07	0.05
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-5.72	-5.85	-5.29	-4.78	-4.20	-3.93	-3.41	-2.69	-2.27	-2.17	-2.00	-1.76
Free Cash Flow Per Share TTM	-3.98	-3.79	-3.66	-3.33	-2.85	-2.79	-2.33	-2.02	-1.74	-1.71	-1.53	-1.45
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	49.60%	63.13%	70.07%	97.80%	106.76%	106.59%	96.65%	73.38%	62.59%	54.20%	42.91%	38.07%
EPS Growth (1Y)	36.17%	49.04%	54.83%	77.87%	85.23%	81.13%	70.94%	52.61%	43.71%	31.54%	21.18%	17.32%
Calculated Values
Free Cash Flow TTM	-312.79M	-275.21M	-263.88M	-239.24M	-203.80M	-185.06M	-153.27M	-130.44M	-111.41M	-99.74M	-87.31M	-82.50M
Net Debt	-159.73M	-261.75M	-115.75M	-127.47M	-120.84M	-145.69M	-369.24M	-77.70M	-98.52M	-85.97M	-88.43M	-70.87M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Insider Transactions

2026-06-09Sale

Owner: Noci, Darlene

Title: Chief Development Officer

Shares: 20,000

Price/Share: $122.81

Value: $2,456,200.00

Shares Owned: 58,117

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Porter, James Richard

Title: President and CEO

Shares: 30,000

Price/Share: $88.80

Value: $2,664,000.00

Shares Owned: 324,879

Relationship: Director,Officer

Ownership: Direct

2026-06-01Sale

Owner: Balcom, Alexandra

Title: Chief Financial Officer

Shares: 11,430

Price/Share: $99.16

Value: $1,133,398.80

Shares Owned: 85,533

Relationship: Officer

Ownership: Direct

2026-05-28Sale

Owner: Noci, Darlene

Title: Chief Development Officer

Shares: 5,500

Price/Share: $108.13

Value: $594,715.00

Shares Owned: 58,117

Relationship: Officer

Ownership: Direct

2026-05-28Sale

Owner: Miller, Deborah Ann

Title: Chief Legal Officer

Shares: 5,500

Price/Share: $107.80

Value: $592,900.00

Shares Owned: 59,634

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-09	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	20,000	122.81	$2,456,200.00	58,117	4
2026-06-08	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	30,000	88.80	$2,664,000.00	324,879	4
2026-06-01	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	11,430	99.16	$1,133,398.80	85,533	4
2026-05-28	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,500	108.13	$594,715.00	58,117	4
2026-05-28	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	5,500	107.80	$592,900.00	59,634	4
2026-05-04	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	30,000	100.95	$3,028,500.00	324,879	4
2026-05-01	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	11,430	99.23	$1,134,198.90	85,533	4
2026-04-30	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	5,500	99.35	$546,425.00	59,634	4
2026-04-29	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,500	100.22	$551,210.00	58,117	4
2026-04-09	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	3,093	104.64	$323,651.52	65,604	4
2026-04-06	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	30,000	104.34	$3,130,200.00	324,879	4
2026-04-01	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	11,430	105.29	$1,203,464.70	85,533	4
2026-03-30	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,500	97.78	$537,790.00	58,117	4
2026-03-26	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	5,500	98.39	$541,145.00	59,634	4
2026-03-25	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	13,700	100.16	$1,372,192.00	85,533	4
2026-03-13	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	5,104	98.81	$504,326.24	65,604	4
2026-03-06	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	30,000	99.36	$2,980,800.00	324,879	4
2026-02-26	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	5,500	103.34	$568,370.00	59,634	4
2026-02-26	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,500	103.44	$568,920.00	58,117	4
2026-01-29	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,500	102.20	$562,100.00	58,117	4
2026-01-22	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	14,300	110.16	$1,575,288.00	59,634	4
2026-01-06	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	3,181	97.49	$310,115.69	81,733	4
2026-01-06	Turner, Christopher Duran…	Officer	Chief Medical Officer	Direct	Sale	3,181	97.49	$310,115.69	55,130	4
2026-01-06	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	9,543	97.49	$930,347.07	278,629	4
2026-01-06	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	2,589	97.49	$252,401.61	42,134	4
2026-01-06	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	3,181	97.49	$310,115.69	40,617	4
2026-01-06	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	2,664	97.49	$259,713.36	65,888	4
2026-01-02	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	10,000	100.76	$1,007,600.00	49,086	4
2025-12-30	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	100.52	$402,080.00	48,034	4
2025-12-08	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	7,084	110.82	$785,048.88	54,650	4
2025-11-28	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	108.28	$433,120.00	48,034	4
2025-11-24	Flynn, James E, Deerfield…	Director,TenPercentOwner,Other	-	Indirect	Sale	742,574	95.45	$70,878,688.30	8,299,225	4
2025-11-24	Shair, Matthew	Director	-	Direct	Sale	5,850	109.16	$638,586.00	1,377,194	4
2025-11-18	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	729	104.08	$75,874.32	61,734	4
2025-11-17	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	24,200	106.06	$2,566,652.00	49,086	4
2025-10-30	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	21,800	101.10	$2,203,980.00	49,086	4
2025-10-30	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	102.26	$409,040.00	48,034	4
2025-10-28	Shair, Matthew	Director	-	Direct	Sale	32,455	100.27	$3,254,262.85	1,383,044	4
2025-10-20	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	5,000	94.91	$474,550.00	49,086	4
2025-10-16	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	12,376	91.47	$1,132,032.72	49,086	4
2025-10-16	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	91.44	$2,468,880.00	249,062	4
2025-10-15	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	14,205	90.04	$1,279,018.20	65,963	4
2025-10-15	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	1,683	85.57	$144,014.31	61,734	4
2025-10-14	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	20,000	87.24	$1,744,800.00	61,734	4
2025-10-14	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	2,433	86.16	$209,627.28	65,963	4
2025-10-01	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	20,000	85.90	$1,718,000.00	61,734	4
2025-09-30	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	20,000	85.06	$1,701,200.00	61,734	4
2025-09-29	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	83.27	$333,080.00	48,034	4
2025-09-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	79.28	$2,140,560.00	249,062	4
2025-09-10	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	3,725	78.83	$293,641.75	65,963	4
2025-08-25	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	74.84	$299,360.00	48,034	4
2025-08-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	76.03	$2,052,810.00	249,062	4
2025-08-07	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	5,500	74.85	$411,675.00	60,956	4
2025-07-30	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	80.36	$321,440.00	48,034	4
2025-07-16	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	14,700	85.10	$1,250,970.00	61,734	4
2025-07-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	83.10	$2,243,700.00	249,062	4
2025-07-10	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	5,500	80.43	$442,365.00	60,956	4
2025-06-27	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	2,170	79.92	$173,426.40	63,101	4
2025-06-27	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	20,000	80.02	$1,600,400.00	61,734	4
2025-06-26	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	78.41	$313,640.00	48,034	4
2025-06-16	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	77.38	$2,089,260.00	249,062	4
2025-06-06	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	200	79.82	$15,964.00	63,101	4
2025-05-29	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	71.46	$285,840.00	48,034	4
2025-05-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	70.01	$1,890,270.00	249,062	4
2025-04-29	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	74.56	$298,240.00	48,034	4
2025-04-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	69.54	$1,877,580.00	249,062	4
2025-03-27	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	73.37	$293,480.00	48,034	4
2025-03-17	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	76.06	$2,053,620.00	249,062	4
2025-03-07	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,000	72.14	$288,560.00	48,034	4
2025-02-24	Shair, Matthew	Director	-	Indirect	Sale	2,000	78.38	$156,760.00	216,522	4
2025-02-18	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	78.72	$2,125,440.00	249,062	4
2025-01-27	Shair, Matthew	Director	-	Indirect	Sale	2,000	83.51	$167,020.00	218,522	4
2025-01-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	76.10	$2,054,700.00	249,062	4
2025-01-06	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	4,016	79.38	$318,790.08	48,034	4
2025-01-06	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	4,016	79.38	$318,790.08	61,734	4
2025-01-06	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	2,483	79.38	$197,100.54	59,981	4
2025-01-06	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	17,301	79.38	$1,373,353.38	249,062	4
2025-01-06	Turner, Christopher Duran…	Officer	Chief Medical Officer	Direct	Sale	4,016	79.38	$318,790.08	62,547	4
2025-01-06	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	2,964	79.38	$235,282.32	49,086	4
2024-12-23	Shair, Matthew	Director	-	Indirect	Sale	2,000	83.90	$167,800.00	220,522	4
2024-12-16	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	86.71	$2,341,170.00	188,113	4
2024-12-11	Hack, Andrew A. F.	Director	-	Indirect	Sale	1,250,000	88.00	$110,000,000.00	1,447,267	4
2024-11-29	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	10,000	95.97	$959,700.00	33,300	4
2024-11-25	Shair, Matthew	Director	-	Indirect	Sale	2,000	96.60	$193,200.00	222,522	4
2024-11-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	88.47	$2,388,690.00	188,113	4
2024-11-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,000	88.94	$444,700.00	33,300	4
2024-10-31	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	10,000	89.67	$896,700.00	33,300	4
2024-10-28	Shair, Matthew	Director	-	Indirect	Sale	2,000	92.23	$184,460.00	224,522	4
2024-10-22	Deerfield, Mgmt L.P., Dee…	Director,TenPercentOwner,Other	-	Indirect	Sale	2,000,000	97.75	$195,500,000.00	8,670,512	4
2024-10-15	Porter, James Richard	Director,Officer	President and CEO	Direct	Sale	27,000	102.64	$2,771,280.00	188,113	4
2024-10-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,000	102.37	$511,850.00	33,300	4
2024-09-30	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	10,000	100.50	$1,005,000.00	33,300	4
2024-09-23	Shair, Matthew	Director	-	Indirect	Sale	2,000	104.43	$208,860.00	226,522	4
2024-09-16	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	8,000	97.46	$779,680.00	33,300	4
2024-09-16	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	32,795	98.26	$3,222,436.70	33,300	4
2024-09-09	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	3,000	87.88	$263,640.00	33,300	4
2024-09-03	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,000	84.72	$423,600.00	33,300	4
2024-08-30	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	10,000	84.79	$847,900.00	33,300	4
2024-08-26	Shair, Matthew	Director	-	Indirect	Sale	2,000	84.71	$169,420.00	228,522	4
2024-08-23	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	11,000	85.04	$935,440.00	33,300	4
2024-08-23	Pelish, Henry E.	Officer	Chief Scientific Officer	Direct	Sale	10,500	85.08	$893,340.00	66,095	4
2024-08-23	Conley, Emily	Director	-	Direct	Sale	3,334	85.02	$283,456.68	2,507	4
2024-08-08	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	3,000	68.01	$204,030.00	33,300	4
2024-08-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,000	78.29	$391,450.00	33,300	4
2024-07-31	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	10,000	79.24	$792,400.00	33,300	4
2024-07-29	Shair, Matthew	Director	-	Indirect	Sale	2,000	80.33	$160,660.00	230,522	4
2024-07-15	Conley, Emily	Director	-	Direct	Sale	5,000	80.76	$403,800.00	2,507	4
2024-07-12	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	6,000	80.16	$480,960.00	33,300	4
2024-07-08	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	3,000	73.07	$219,210.00	33,300	4
2024-07-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	5,000	75.82	$379,100.00	33,300	4
2024-06-28	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	10,000	76.02	$760,200.00	33,300	4
2024-06-24	Shair, Matthew	Director	-	Indirect	Sale	2,000	80.32	$160,640.00	232,522	4
2024-06-14	Conley, Emily	Director	-	Direct	Sale	5,000	77.91	$389,550.00	2,507	4
2024-06-06	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	8,000	78.11	$624,880.00	33,300	4
2024-05-28	Shair, Matthew	Director	-	Indirect	Sale	2,000	67.77	$135,540.00	234,522	4
2024-05-15	Conley, Emily	Director	-	Direct	Sale	5,000	69.09	$345,450.00	8	4
2024-05-13	Shair, Matthew	Director	-	Direct	Sale	37,500	66.13	$2,479,875.00	1,424,698	4
2024-05-06	Shair, Matthew	Director	-	Direct	Sale	37,500	69.77	$2,616,375.00	1,462,198	4
2024-05-02	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	3,000	72.42	$217,260.00	33,300	4
2024-04-29	Shair, Matthew	Director	-	Direct	Sale	37,500	67.80	$2,542,500.00	1,499,698	4
2024-04-22	Shair, Matthew	Director	-	Direct	Sale	37,500	63.66	$2,387,250.00	1,537,198	4
2024-04-15	Shair, Matthew	Director	-	Direct	Sale	37,500	65.72	$2,464,500.00	1,574,698	4
2024-04-15	Conley, Emily	Director	-	Direct	Sale	5,000	66.09	$330,450.00	8	4
2024-04-08	Shair, Matthew	Director	-	Direct	Sale	37,500	68.72	$2,577,000.00	1,612,198	4
2024-04-04	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	3,000	73.19	$219,570.00	33,300	4
2024-04-01	Shair, Matthew	Director	-	Direct	Sale	37,500	77.00	$2,887,500.00	1,649,698	4
2024-03-28	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	22,000	75.13	$1,652,860.00	33,300	4
2024-03-27	Hack, Andrew A. F.	Director	-	Indirect	Sale	880,000	74.60	$65,648,000.00	2,697,267	4
2024-03-25	Shair, Matthew	Director	-	Direct	Sale	37,500	77.06	$2,889,750.00	1,687,198	4
2024-03-22	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	20,000	77.97	$1,559,400.00	33,300	4
2024-03-15	Conley, Emily	Director	-	Direct	Sale	13,333	81.69	$1,089,172.77	8	4
2023-12-28	Shair, Matthew	Director	-	Direct	Sale	48,548	75.67	$3,673,627.16	1,724,698	4
2023-12-19	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	5,000	75.00	$375,000.00	0	4
2023-12-18	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	30,000	75.82	$2,274,600.00	0	4
2023-12-18	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	40,000	75.82	$3,032,800.00	0	4
2023-12-18	Protopapas, Anna	Director	-	Direct	Sale	5,000	75.67	$378,350.00	0	4
2023-11-28	Shair, Matthew	Director	-	Direct	Sale	9,150	62.02	$567,483.00	1,843,848	4
2023-11-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	3,000	52.31	$156,930.00	0	4
2023-10-24	Shair, Matthew	Director	-	Direct	Sale	91,700	50.93	$4,670,281.00	1,852,998	4
2023-10-04	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	20,000	56.47	$1,129,400.00	0	4
2023-10-04	Turner, Christopher Duran…	Officer	Chief Medical Officer	Direct	Sale	7,995	55.01	$439,804.95	14,513	4
2023-10-02	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	3,000	46.12	$138,360.00	0	4
2023-09-15	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	2,000	47.71	$95,420.00	0	4
2023-09-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	3,000	46.49	$139,470.00	0	4
2023-08-15	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	2,000	42.74	$85,480.00	0	4
2023-08-01	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	3,000	49.88	$149,640.00	0	4
2023-07-31	Balcom, Alexandra	Officer	Chief Financial Officer	Direct	Sale	25,000	49.05	$1,226,250.00	0	4
2023-07-28	Turner, Christopher Duran…	Officer	Chief Medical Officer	Direct	Sale	2,665	48.93	$130,398.45	14,513	4
2023-07-28	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	6,500	48.52	$315,380.00	0	4
2023-07-24	Turner, Christopher Duran…	Officer	Chief Medical Officer	Direct	Sale	200	46.82	$9,364.00	14,513	4
2023-07-20	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	10,941	45.17	$494,204.97	0	4
2023-07-17	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	2,000	42.74	$85,480.00	0	4
2023-07-03	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	3,000	41.72	$125,160.00	0	4
2023-06-16	Noci, Darlene	Officer	Chief Development Officer	Direct	Sale	2,900	45.19	$131,051.00	0	4
2023-06-15	Miller, Deborah Ann	Officer	Chief Legal Officer	Direct	Sale	2,000	44.05	$88,100.00	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Institutional Ownership

No data available for chart

2026-03-31

94.47%

Inst. Shares: 74,319,315

Shares Outstanding: 78,670,371

2025-12-31

104.59%

Inst. Shares: 76,025,142

Shares Outstanding: 72,686,749

2025-09-30

96.37%

Inst. Shares: 69,521,316

Shares Outstanding: 72,143,466

2025-06-30

95.71%

Inst. Shares: 68,765,259

Shares Outstanding: 71,843,774

2025-03-31

97.22%

Inst. Shares: 69,616,579

Shares Outstanding: 71,607,546

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	74,319,315	78,670,371	94.47%
2025-12-31	76,025,142	72,686,749	104.59%
2025-09-30	69,521,316	72,143,466	96.37%
2025-06-30	68,765,259	71,843,774	95.71%
2025-03-31	69,616,579	71,607,546	97.22%
2024-12-31	68,600,316	66,408,807	103.30%
2024-09-30	68,300,380	65,678,693	103.99%
2024-06-30	64,422,360	64,605,308	99.72%
2024-03-31	61,830,137	64,150,588	96.38%
2023-12-31	61,849,816	58,223,339	106.23%
2023-09-30	54,862,098	57,091,394	96.10%
2023-06-30	53,319,483	56,866,991	93.76%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Nuvalent, Inc. (NUVL) — SEC Financial Statements & Analysis

Nuvalent, Inc. (NUVL) is a pharmaceutical preparations company, incorporated in DE. Nuvalent, Inc. trades on Nasdaq as: NUVL. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Nuvalent, Inc. reported a Debt-to-Equity ratio of 0.13x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.13x

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Nuvalent, Inc. in?

Nuvalent, Inc. (NUVL) operates in the Pharmaceutical Preparations industry.

What exchange does NUVL trade on?

Nuvalent, Inc. (NUVL) trades on the Nasdaq.

Where is Nuvalent, Inc. incorporated?

Nuvalent, Inc. is incorporated in DE.

Nuvalent, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Nuvalent, Inc. (NUVL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Nuvalent, Inc. (NUVL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.